Claglid MV 0.3mg/500mg/30mg Tablet
Prescription Required
Introduction of Claglid MV Tablet
Claglid MV 0.3mg/500mg/30mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Claglid MV 0.3mg/500mg/30mg Tablet is used in the treatment of type 2 diabetes. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. It should be used along with proper diet and regular exercise for best results. Monitor your blood sugar level regularly while you are taking this medicine as it may cause hypoglycemia (low blood sugar level).
Claglid MV 0.3mg/500mg/30mg Tablet is used in the treatment of type 2 diabetes. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. It should be used along with proper diet and regular exercise for best results. Monitor your blood sugar level regularly while you are taking this medicine as it may cause hypoglycemia (low blood sugar level).
Uses of Claglid MV Tablet
Benefits of Claglid MV Tablet
In Treatment of Type 2 diabetes mellitus
Claglid MV 0.3mg/500mg/30mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.
Claglid MV 0.3mg/500mg/30mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Claglid MV 0.3mg/500mg/30mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of Claglid MV Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Claglid MV
- Hypoglycemia (low blood glucose level)
- Nausea
- Taste change
- Diarrhea
- Stomach pain
- Flatulence
- Headache
- Skin rash
- Respiratory tract infection
How to use Claglid MV Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Claglid MV 0.3mg/500mg/30mg Tablet is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Claglid MV 0.3mg/500mg/30mg Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Claglid MV 0.3mg/500mg/30mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Claglid MV 0.3mg/500mg/30mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
CAUTION
Claglid MV 0.3mg/500mg/30mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Claglid MV 0.3mg/500mg/30mg Tablet may be needed. Please consult your doctor.
Use of Claglid MV 0.3mg/500mg/30mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Use of Claglid MV 0.3mg/500mg/30mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Liver
CAUTION
Claglid MV 0.3mg/500mg/30mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Claglid MV 0.3mg/500mg/30mg Tablet may be needed. Please consult your doctor.
Claglid MV 0.3mg/500mg/30mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Claglid MV 0.3mg/500mg/30mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Claglid MV 0.3mg/500mg/30mg Tablet
₹8.0/Tablet
Carryl MV 30 Tablet
4Care Lifescience Pvt Ltd
₹11/tablet
45% costlier
Quick tips
Claglid MV Tablet
- Take it with food to lower your chance of having an upset stomach.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 08 Apr. 2019] (online) Available from:
- Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003. [Accessed 12 Mar. 2019] (online) Available from:
- Gliclazide+Metformin+Voglibose [Product Monograph]. Solan, Himachal Pradesh: Panacea Biotec Limited; 2019. [Accessed 21 Oct. 2021] (online) Available from:
- American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S98-S110. [Accessed 21 Oct. 2021] (online) Available from:
Marketer details
Name: Proqol Healthcare
Address: Proqol Healthcare Pvt. Ltd., No 6 , Shop No 5, 2nd Floor, Sneham Commercial complex, MTH Road, Padi, Chennai- 600050
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹80
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me